Latest filing published 30 Dec 2025 for Enveric Biosciences, Inc..
No signal scores available.
Kevin Michael Coveney appears in our data through filings on Enveric Biosciences, Inc. shares, published by SEC (Form 4). Between 13 March 2023 and 23 December 2025, the trades on record add up to 5 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 30 December 2025, reports a share grant in Enveric Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations